CutisPharma closes equity financing with Ampersand
CutisPharma has closed an equity financing with Ampersand Capital Partners. As a part of the transaction, Silicon Valley Bank has provided a senior credit facility to further support the Company's growth requirements. In conjunction with the financing, two Ampersand partners, Eric Lev and David Parker, have joined the CutisPharma Board




